Trending Stories on Eyewire+
Sydnexis Announces FDA Acceptance of NDA for SYD-101 for the Treatment of Progression of Pediatric Myopia
Sydnexis announced that the FDA has accepted its new drug application (NDA) for SYD-101, which if approved would be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States.The FDA assigned a Prescription Drug User Fee Act (PDUFA) target action date of October 23, 2025. Read More
Bausch + Lomb Launches Arise Orthokeratology Lens System in the US
Bausch + Lomb announced the US launce of Arise, a lens fitting system designed to use intelligent, cloud-based technology to streamline the orthokeratology lens design process. Orthokeratology is a non-surgical method of vision correction that uses rigid, gas-permeable contact lenses to temporarily reshape the cornea specifically designed for individual patients. Read More
Atsena Granted FDA Fast Track Designation for Gene Therapy to Treat X-linked Retinoschisis
Atsena Therapeutics announced that the FDA has granted Fast Track designation for gene therapy product candidate, ATSN-201, for the treatment of X-linked retinoschisis (XLRS). ATSN-201 leverages AAV.SPR, the company’s novel spreading capsid, to achieve therapeutic levels of gene expression in photoreceptors of the central retina while avoiding the surgical risks of foveal detachment. Read More
EyewireTV | 3.12.2025
The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Click here to check it out!
Latest In Podcasts
Building Strong Practice Partnerships
Neda Nikpoor, and Neda Shamie, MD, examine the key elements of successful practice partnerships in ophthalmology. They discuss how junior and senior partners can build strong, collaborative relationships through mentorship, strategic recruitment, clear communication, and aligned expectations. They highlight the importance of trust, flexibility, and long-term vision in fostering a thriving and sustainable practice. Click here to catch the latest episode.
Learn How Vitamin A Supports the Ocular Surface
Jackie Garlich, O.D., F.A.A.O, and Jessilin Quint, OD, MBA, MS, FAAO have a conversation with Kaleb Abbott, OD, MS, FAAO, FOWNS, on the importance of vitamin A in maintaining ocular surface health. Dr. Abbott discusses the various forms of vitamin A, where it can be obtained, settings in which it can be potentially harmful to the ocular surface, signs and symptoms of deficiency, and more. Click here to catch the latest episode.
Eyewire News: The Podcast
Haag-Streit launches the METIS 900 ophthalmic microscope system; the FDA accepts Glaukos’ NDA for Epi-on cross-linking; and Optos releases its next generation ultra-widefield SLO imaging technology. Catch the latest episodes here!
Latest in Subspecialties:
CATARACT: Management of Extensive Cyclodialysis Clefts
GLAUCOMA: Study Finds Most Glaucoma Patients Unaware of Preservative-Free Treatment Options
OPTOMETRY: A New Approach to Treating Keratoconus - Significant Findings
Thank you for reading! We'll be back next week with another edition of Eyewire+ Weekly Digest. For the most up to date news, please visit us at Eyewire+.